2025 annual financial data
Ovid Therapeutics 2025 Operating margin
Direct answer
Operating margin was -585.2%.
Operating income was -42,439,000 USD and net income was -17,414,000 USD.
Operating cash flow was -38,334,000 USD.
Get free Ovid Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 7,252,000 USD
- Operating income
- -42,439,000 USD
- Net income
- -17,414,000 USD
- Operating cash flow
- -38,334,000 USD